Healthzone Limited (asx:hzl) Launches Adr Program And Otcqx Quotation In The Usa

HEALTHZONE LAUNCHES ADR PROGRAM AND OTCQX QUOTATION IN THE USA


Leading distributor, franchise retailer and producer of health and beauty products, Healthzone Limited (ASX code: HZL), is pleased to announce the official launch of its American Depositary Receipt (ADR) program and dual quotation on the OTCQX exchange in the United States of America.

The ADR program will enable North American investors to buy Healthzone shares in the United States of America like USA based companies and with quotation of Healthzone securities in U.S. dollars in the form of ADR's on the OTCQX. Healthzone will maintain its primary listing on the Australian Securities Exchange (ASX) with access to larger North American capital markets, which have trading volumes of approximately 50 times that of the ASX, through its American Depositary Receipt Program.

Healthzone's ADR program is sponsored by BNY Mellon, the leading depositary bank, managing substantially more sponsored Depositary Receipt programs than any other depositary bank in the world, with Depositary Receipts issued for more than 2,250 programs with companies from 70 countries. The Bank of New York has more than US$20 trillion in assets under custody, with more than US$900 billion in assets under management.

Further growth will be facilitated by Healthzone's dual listing on the OTCQX (www.otcqx.com), which is the premier over-the-counter securities exchange in the USA. The OTCQX is estimated to have market capitalisation of more than 50 per cent of the ASX and with its admission to the OTCQX, Healthzone will join global companies which have dual listings on the OTCQX, including Adidas, Air France, Allianz, Azko Nobel, Bennetton, Marks & Spencer and Peugeot.

In commenting on this Company milestone, Peter Roach, Chairman, Healthzone, said, "This is a major milestone in the development of Healthzone's international profile and markets. The ADR and OTCQX Programs will enable international investors to participate more easily in Healthzone's international growth and is expected to provide a range of benefits to Healthzone, including international profile, support by strategic investors in international markets and enhancing the liquidity of Healthzone securities in international capital markets, which is expected to enhance Healthzone's enterprise value."

Healthzone expects to make further announcements in the near future regarding the active support of the Company by brokers and institutions in the North America and Europe.


For more information, visit the website www.healthzone.com.au
or contact Rod North,
Bourse Communications,
(03) 9510 8309
or 0408 670 706

ACN 118715772
316 Horsley Road
ASX/MEDIA RELEASE Milperra NSW 2214

SOURCE: Healthzone Limited